The current stock price of LFST is 6.47 USD. In the past month the price increased by 32.38%. In the past year, price decreased by -13.56%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.61 | 100.93B | ||
| CI | THE CIGNA GROUP | 9.76 | 74.05B | ||
| LH | LABCORP HOLDINGS INC | 17.12 | 22.46B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 119.65 | 22.01B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.03 | 20.67B | ||
| GH | GUARDANT HEALTH INC | N/A | 13.56B | ||
| HIMS | HIMS & HERS HEALTH INC | 71.81 | 8.83B | ||
| DVA | DAVITA INC | 13.02 | 8.49B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 35.58 | 6.54B | ||
| RDNT | RADNET INC | 215.7 | 6.32B | ||
| CHE | CHEMED CORP | 20.02 | 6.24B | ||
| OPCH | OPTION CARE HEALTH INC | 20.73 | 4.90B |
Lifestance Health Group, Inc. provides outpatient mental health services. The company is headquartered in Scottsdale, Arizona and currently employs 7,708 full-time employees. The company went IPO on 2021-06-10. The firm is focused on providing virtual and in-person outpatient mental healthcare for children, adolescents and adults experiencing a variety of mental health conditions. Its patient-focused platform combines differentiated clinical capabilities with a personalized, digitally powered patient experience designed to transform patient access and treatment. Its clinicians offer patients a comprehensive, multidisciplinary suite of mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. The company treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders and post-traumatic stress disorder. The company employs approximately 7,400 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers.
LIFESTANCE HEALTH GROUP INC
4800 N. Scottsdale Road, Suite 2500
Scottsdale ARIZONA US
CEO: Michael K. Lester
Employees: 7708
Phone: 16027672100
Lifestance Health Group, Inc. provides outpatient mental health services. The company is headquartered in Scottsdale, Arizona and currently employs 7,708 full-time employees. The company went IPO on 2021-06-10. The firm is focused on providing virtual and in-person outpatient mental healthcare for children, adolescents and adults experiencing a variety of mental health conditions. Its patient-focused platform combines differentiated clinical capabilities with a personalized, digitally powered patient experience designed to transform patient access and treatment. Its clinicians offer patients a comprehensive, multidisciplinary suite of mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. The company treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders and post-traumatic stress disorder. The company employs approximately 7,400 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers.
The current stock price of LFST is 6.47 USD. The price decreased by -0.46% in the last trading session.
LFST does not pay a dividend.
LFST has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
LIFESTANCE HEALTH GROUP INC (LFST) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.03).
LIFESTANCE HEALTH GROUP INC (LFST) has a market capitalization of 2.52B USD. This makes LFST a Mid Cap stock.
You can find the ownership structure of LIFESTANCE HEALTH GROUP INC (LFST) on the Ownership tab.
ChartMill assigns a technical rating of 8 / 10 to LFST. When comparing the yearly performance of all stocks, LFST turns out to be only a medium performer in the overall market: it outperformed 56.62% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to LFST. LFST scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months LFST reported a non-GAAP Earnings per Share(EPS) of -0.03. The EPS increased by 88.46% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -0.42% | ||
| ROE | -0.61% | ||
| Debt/Equity | 0.18 |
14 analysts have analysed LFST and the average price target is 8.74 USD. This implies a price increase of 35.13% is expected in the next year compared to the current price of 6.47.
For the next year, analysts expect an EPS growth of 80.88% and a revenue growth 14.25% for LFST